Effect Of Triamcinolone Trigger Point Injection On Changes In TNF-α Levels And Oswestry Disability Index (ODI) Scores Non-Specific Low Back Pain (LBP) Patients
DOI:
https://doi.org/10.36408/mhjcm.v11i1.976Keywords:
triamcinolone, Trigger Point Injection, TNF-α, ODIAbstract
Background: Low back pain (LBP) is the most common musculoskeletal problem and a major cause of worldwide disability causing increased health costs and indirect costs associated with reduced or lost productivity. One of the therapeutic management of LBP is Triamcinolone trigger point injection. Until now, research on the effect of Triamcinolone trigger point injection on changes in TNF-α levels and Oswestry Disability Index (ODI) scores in Non-Specific LBP patients is still limited.
Objective: To analyze the effect of Triamcinolone trigger point injection on changes in TNF-α levels and ODI scores before and after Triamcinolone trigger point injection in Non-Specific LBP patients.
Methods: This is a quasi-experimental analytic observational study with a pre and post-test group design approach. Subjects were diagnosed with Non-Specific LBP who had met the inclusion criteria (acute pain less than 3 months, patient age 30-55 years, moderate-severe pain intensity, had never received a Triamcinolone trigger point injection) with the exclusion criteria patients experiencing severe pain. not only caused by NPB. The study subjects were checked for TNF-α levels and ODI scores before and after the Triamcinolone trigger point injection. Then a paired T-test was carried out.
Results: During the study period September - November 2022 at the Neurology Outpatient Polyclinic, RSUP Dr. Kariadi Semarang obtained 32 subjects. There was a significant difference between changes in TNF-α levels before and after Triamcinolone trigger point injection (p=0.000). There was a significant difference in ODI scores before and after the Triamcinolone trigger point injection (p=0.000). There was no significant relationship between the risk factors for gender, occupation, BMI, physiotherapy, and changes in TNF-α levels with changes in the ODI score.
Conclusion: There is a significant difference in changes in TNF-α levels and ODI scores before and after Triamcinolone trigger point injection.
Downloads
References
1. Fatoye F, Gebrye T OI. Real-world incidence and prevalence of low back pain using routinely collected data. Rheumatol Int. 2019;39:619–626.
2. Wu A, March L, Zheng X, Huang J et al. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Ann Transl Med. 2020;8(6):299.
3. Urits I, Burshtein A, Sharma M, Testa L et al. Low Back Pain, a Comprehensive Review: Pathophysiology, Diagnosis, and Treatment. Curr Pain Headache Rep. 2019;23:23.
4. Gorth DJ, Shapiro IM RM V. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2018;10(1):7. doi:10.1038/s41419-018-1246–x.
5. WHO. International classification of functioning, disability and health: ICF. In Geneva, Switzerland; 2001.
6. Liu X-G, Hou H-W LY-L. Expression levels of IL-17 and TNF-α in degenerated lumbar intervertebral discs and their correlation. Exp Ther Med. 2016;11(6):2333-2340. doi:10.3892/etm.2016.3250.
7. Sungkar A, Widyatmoko D, Yarso KY WB. The effect of duration of wound skin tissue on MDA, TNF-α, IL-6, Caspase 3, VEGF levels, and granulation tissue thickness in the white rat (Rattus novergicus). Bali MedJournal. 2020;9(3):918-923.
8. Siebelt M, Korthagen N, Wei W, Groen H, Bastiaansen-Jenniskens Y, Müller C et al. Triamcinolone acetonide activates an antiinflammatory and folate receptor-positive macrophage that prevents osteophytosis in vivo. Arthritis Res Ther. 2015;17:352.
9. Saeidian SR, Pipelzadeh MR, Rasras S, Zeinali M. Effect of trigger point injection on lumbosacral radiculopathy source. Anesthesiol Pain Med. 2014;4(4):1–4.
10. Asiri F, Tedla J, Alshahrani M, Ahmed I, Reddy R GK. Effects of patient-specific three-dimensional lumbar traction on pain and functional disability in patients with lumbar intervertebral disc prolapse. Niger J Clin Pr. 2020;23(4):498–502.
11. Sciotti VM, Mittak VL, DiMarco L, Ford LM, Plezbert J, Santipadri E et al. Clinical precision of myofascial trigger point location in the trapezius muscle. Pain. 2001;93(3):259–.
12. Eftekharsadat B, Fasaie N, Golalizadeh D, Babaei-Ghazani A, Jahanjou F, Eslampoor Y, et al. Comparison of efficacy of corticosteroid injection versus extracorporeal shock wave therapy on inferior trigger points in the quadratus lumborum muscle: a randomized clinical trial. BMC Musculoskeletal Disorder. 2020;21(1):1–11.
13. Strong JA, Xie W, Bataille FJ, Zhang JM. Preclinical studies of low back pain. Mol Pain. 2013;9(1):1–9.
14. Andrade P, Visser-Vandewalle V, Hoffmann C, Steinbusch HW DM, Preclinical HG. Role of TNF-alpha during central sensitization. Neurol Sci. 2011;32:757–771.
15. Knezevic NN, Jovanovic F, Voronov D, Candido KD. Do corticosteroids still have a place in the treatment of chronic pain? Front Pharmacol. 2018;9(NOV).
16. Risbud, MV, and Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10, 44–56.
17. Bahar Dernek, Levent Adiyeke , Tahir Mutlu Duymus , Akın Gokcedag , Fatma Nur Kesiktas CA. Efficacy of Trigger Point Injections in Patients with Lumbar Disc Hernia without Indication for Surgery. Asian Spine J. 2018;12(2):232-237.
18. Hodges PW, Danneels L. Changes in structure and function of the back muscles in low back pain: Different time points, observations, and mechanisms. J Orthop Sports Phys Ther. 2019;49(6):464–76.
19. Quan M, Park SE, Lin Z, Hong MW, Park SY, Kim YY. Steroid treatment can inhibit nuclear localization of members of the NF-κB pathway in human disc cells stimulated with TNF-α. Eur J Orthop Surg Traumatol. 2015;25(977):43–51.
20. Khan AN, Jacobsen HE, Khan J, Filippi CG, Levine M, Lehman RA, et al. Inflammatory biomarkers of low back pain and disc degeneration: a review. Ann NY Acad Sci. 2017;1410(1):68–84.
21. De Queiroz BZ, Pereira DS, Lopes RA et al. Association Between the Plasma Levels of Mediators of Inflammation With Pain and Disability in the Elderly With Acute Low Back Pain: Data From the Back Complaints in the Elders (BACE)-Brazil Study. Spine J. 2016;41(3):197-203. doi:10.1097/BRS.0000000000001214.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2024 Mohamad Fakih, Suryadi, Dodik Tugasworo, Dwi Pudjanarko, Amin Husni, Trianggoro Budisulistyo, Arinta Puspitawati (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
